Literature DB >> 10750216

QT lengthening and life-threatening arrhythmias associated with fexofenadine.

P M Craig-McFeely, S L Freemantle, G L Pearce, S A Shakir.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10750216      PMCID： PMC1313636     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  4 in total

1.  Non-antiarrhythmic drugs prolonging the QT interval: considerable use in seven countries.

Authors:  Fabrizio De Ponti; Elisabetta Poluzzi; Alberto Vaccheri; Ulf Bergman; Lars Bjerrum; John Ferguson; Kerry J Frenz; Peter McManus; Ingrid Schubert; Gisbert Selke; Georgia Terzis-Vaslamatzis; Nicola Montanaro
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

Review 2.  Second-generation antihistamines: actions and efficacy in the management of allergic disorders.

Authors:  Larry K Golightly; Leon S Greos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Fexofenadine hydrochloride in the treatment of allergic disease: a review.

Authors:  David Axelrod; Leonard Bielory
Journal:  J Asthma Allergy       Date:  2008-09-19

4.  Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across Europe.

Authors:  Elisabetta Poluzzi; Emanuel Raschi; Brian Godman; Ariola Koci; Ugo Moretti; Marija Kalaba; Bjorn Wettermark; Miriam Sturkenboom; Fabrizio De Ponti
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.